Market Overview

Global $2.978 Bn Hydroxyapatite Market 2018-2023 - Continuous R&D Activities to Increase the Applicability of HAp in the Medical Industry

Share:

Global $2.978 Bn Hydroxyapatite Market 2018-2023 - Continuous R&D Activities to Increase the Applicability of HAp in the Medical Industry

PR Newswire

DUBLIN, Aug. 15, 2018 /PRNewswire/ --

The "Hydroxyapatite Market by Type (Nano-sized, Micro-sized, Greater than Micrometers), Application (Orthopedic, Dental Care, Plastic Surgery), and Region (North America, Europe, Asia-Pacific, and Rest of the World) - Global Forecast to 2023" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

The Hydroxyapatite (HAp) market is projected to grow from USD 2.22 billion in 2018 to USD 2.97 billion by 2023, at a CAGR of 5.9% between 2018 and 2023.

The HAp market is projected to grow at a significant rate during the forecast period due to the increasing consumer awareness about bioactive ceramics and growing healthcare expenditure across the globe.

Based on type, the HAp market has been segmented into nano-sized, micro-sized, and greater than micrometers. The micro-sized segment accounted for the largest share of the HAp market in 2017. The micro-sized hydroxyapatite is primarily used as an alternative to allogeneic and xenogeneic bone grafts. It is also used as a bone cement to fill voids in bones and teeth. Micro-sized hydroxyapatite is also used as a coating for implants and screws. The micro-sized hydroxyapatite is used in the pharmaceutical applications for controlled delivery of genes and proteins to the target tissues.

Based on application, the HAp market has been segmented into orthopedic, dental care, plastic surgery, and others. The orthopedic segment led the HAp market in 2017. This segment of the market is projected to lead the market during the forecast period as well. Hydroxyapatite is used as a coating for implants, bone grafts, and bone fillers. Due to its bioactivity, hydroxyapatite is used as an alternative to allogeneic and xenogeneic bone grafts, resulting in the reduced healing time required. The aging global population and growing demand for bioactive ceramics in the bone replacement surgeries are driving the demand for hydroxyapatite in the orthopedic applications.

The North American region accounted for the largest share of the HAp market in 2017. It is projected to lead the HAp market during the forecast period as well. The Asia Pacific HAp market is projected to grow at the highest CAGR during the forecast period. The increased demand for hydroxyapatite from countries such as China, Japan, and South Korea is driving the growth of the Asia Pacific HAp market.

Moreover, the aging population, increasing disposable income of the middle-class population, and growing awareness among masses about the advantages of dental bone grafting and bone grafting over traditional treatments provide a huge growth opportunity for the manufacturers of hydroxyapatite in the Asia Pacific region.

The major restraints for the HAp market are unfavorable healthcare reforms in the US and unmet performance benchmark by hydroxyapatite such as its low fracture toughness.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

4.1 Attractive Growth Opportunity for HAp Market
4.2 APAC HAp Market, By Application
4.3 HAp Market, By Application
4.4 HAp Market, By Region

5 Market Overview

5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Continuous R&D Activities to Increase the Applicability of HAp in the Medical Industry
5.2.1.2 Growing Demand for Implants
5.2.2 Restraints
5.2.2.1 Unfavorable Healthcare Reforms in the US
5.2.3 Opportunities
5.2.3.1 Growing Healthcare Industry and Easy Availability of Raw Materials in APAC
5.2.4 Challenges
5.2.4.1 Unmet Performance Benchmark and Increasing Popularity of Bioresorbable Composites
5.3 Porter's Five Forces Analysis
5.3.1 Bargaining Power of Buyers
5.3.2 Bargaining Power of Suppliers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Intensity of Competitive Rivalry

6 Hydroxyapatite Market, By Type

6.1 Introduction
6.2 Nano-Sized
6.3 Micro-Sized
6.4 Greater Than Micrometer

7 Hydroxyapatite Market, By Application

7.1 Introduction
7.2 Orthopedic
7.3 Dental Care
7.4 Plastic Surgery
7.5 Others

8 HAp Market, By Region

8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Rest of North America
8.3 Europe
8.3.1 France
8.3.2 Russia
8.3.3 Germany
8.3.4 UK
8.3.5 Portugal
8.3.6 Rest of Europe
8.4 APAC
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Rest of APAC
8.5 Rest of the World

9 Company Profiles

9.1 Fluidinova
9.2 Sofsera
9.3 Berkeley Advanced Biomaterials
9.4 Taihei Chemical Industrial Co. Ltd.
9.5 Sigmagraft
9.6 Cam Bioceramics
9.7 Zimmer Biomet
9.8 APS Materials
9.9 CG Bio Inc.
9.10 Granulab (M) Sdn Bhd

For more information about this report visit https://www.researchandmarkets.com/research/slnltd/global_2_978_bn?w=5

Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Cision View original content:http://www.prnewswire.com/news-releases/global-2-978-bn-hydroxyapatite-market-2018-2023---continuous-rd-activities-to-increase-the-applicability-of-hap-in-the-medical-industry-300697545.html

SOURCE Research and Markets

View Comments and Join the Discussion!